Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",18431,149,1.17 [0.88-1.55],0.2911705834729949
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",19372,199,0.87 [0.65-1.17],0.3616968500601313
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",19140,1391,1.02 [0.92-1.13],0.7465272701222304
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Candidiasis,19388,440,1.07 [0.90-1.28],0.4278414833767808
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,18742,3412,1.03 [0.96-1.09],0.446560531793618
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),18732,3463,1.02 [0.95-1.08],0.6311673175164847
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,19141,1146,1.11 [1.00-1.23],0.0582325672527819
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,19300,105,0.93 [0.63-1.38],0.73082045781496
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,17106,1008,1.01 [0.90-1.14],0.8850349315708133
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,16479,1217,1.05 [0.95-1.17],0.3445786180658573
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,16151,264,1.17 [0.95-1.44],0.1471218162821143
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,12636,2189,1.05 [0.97-1.14],0.2654933080158932
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,16098,389,0.99 [0.82-1.21],0.9592615918490554
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,19351,1356,1.08 [0.98-1.19],0.131077407327768
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Mycoses,19456,508,1.07 [0.91-1.26],0.4336787152359134
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,18728,979,1.02 [0.90-1.15],0.7522890885018362
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,19398,1116,1.02 [0.91-1.14],0.7407813375013896
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,18194,199,0.88 [0.66-1.18],0.4018871271945153
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,19505,49,0.88 [0.48-1.58],0.6615722081269586
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other septicaemia,19254,972,1.00 [0.89-1.14],0.9387519469907464
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,19257,62,0.88 [0.52-1.48],0.6223119594466736
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other viral diseases,19450,108,0.89 [0.60-1.32],0.5746565513782131
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",19435,93,0.92 [0.61-1.40],0.7056133843717733
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,18134,385,1.09 [0.91-1.31],0.3613952553101052
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,17996,247,0.94 [0.73-1.21],0.6187833776826954
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,18096,101,1.15 [0.82-1.63],0.4149037823071529
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,19490,45,1.09 [0.62-1.91],0.759742739487878
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,19446,149,0.91 [0.66-1.27],0.5926574724381473
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Viral warts,19346,49,1.10 [0.65-1.84],0.7291046106776232
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],19367,70,0.84 [0.51-1.39],0.4925035699538087
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign lipomatous neoplasm,19265,220,0.90 [0.69-1.19],0.4702294222670692
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,19433,37,1.36 [0.81-2.28],0.243268391339487
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,19419,39,0.61 [0.29-1.30],0.200718524755899
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,9244,66,0.76 [0.44-1.30],0.3165791495689836
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",19118,1405,0.90 [0.81-1.01],0.0698039369135558
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm of meninges,19491,55,1.27 [0.82-1.95],0.2805650651481378
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,19423,69,1.41 [0.99-2.01],0.0552539808201841
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,19482,100,0.65 [0.41-1.03],0.0651025417628627
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm of ovary,10210,62,0.80 [0.47-1.39],0.4340589600219041
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm: Ascending colon,19471,380,0.95 [0.78-1.16],0.631920076191427
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm: Caecum,19483,322,0.97 [0.78-1.21],0.7942693791108236
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",19381,72,0.86 [0.53-1.41],0.5561576129703819
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm: Descending colon,19469,218,0.95 [0.73-1.24],0.7096180650510155
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm: Rectum,19426,339,0.91 [0.73-1.14],0.4256001673067336
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,19376,589,0.99 [0.85-1.17],0.944029399657444
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm: Transverse colon,19463,447,0.85 [0.70-1.03],0.1024606723803338
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Carcinoma in situ of breast,7686,45,1.45 [0.92-2.26],0.1073821122919737
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",7718,54,1.14 [0.70-1.85],0.5923880690198906
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",13994,60,1.21 [0.78-1.88],0.4002870976276608
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",14018,84,1.03 [0.68-1.54],0.8952804401612457
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",19456,107,1.19 [0.86-1.65],0.3036006854866773
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Haemangioma, any site",19457,104,1.21 [0.87-1.67],0.2603499729578945
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Leiomyoma of uterus,9978,146,1.22 [0.92-1.61],0.1634601561272611
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Lung cancer and mesothelioma,12448,419,1.01 [0.85-1.20],0.9326000939243126
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Lymphoid leukaemia,13996,62,1.13 [0.72-1.77],0.6035216234292424
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",14121,187,1.01 [0.77-1.34],0.9250174917143706
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",14190,256,0.82 [0.63-1.07],0.1385257104570059
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",7799,96,1.07 [0.74-1.54],0.7352192078384461
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",14023,89,1.21 [0.86-1.72],0.2743325964263861
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",14054,120,0.60 [0.39-0.93],0.0206060342699006
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",14043,109,1.00 [0.69-1.45],0.9798313157399876
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",7783,80,0.89 [0.56-1.40],0.6114913119649648
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",14037,103,1.08 [0.75-1.55],0.6847600789446093
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",7032,801,0.91 [0.79-1.05],0.1964669547897326
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",14046,112,1.26 [0.93-1.70],0.1361919836719255
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",14015,81,0.92 [0.59-1.44],0.7268001700354916
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,14051,117,0.93 [0.64-1.35],0.6900049820630408
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Melanocytic naevi,19384,155,0.81 [0.57-1.14],0.223130510465136
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Melanocytic naevi of trunk,19481,67,0.71 [0.41-1.22],0.2159859243066212
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Melanoma in situ,13980,98,1.02 [0.70-1.49],0.9185707141191672
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",14036,102,1.09 [0.77-1.56],0.617776929510538
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",14103,169,0.92 [0.68-1.25],0.5857218591571465
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",14223,289,0.94 [0.74-1.20],0.6258596555369773
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",14042,108,0.89 [0.60-1.31],0.5545611321698388
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Other benign neoplasms of skin,19360,145,0.82 [0.57-1.16],0.2585098174975591
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",15161,1227,1.04 [0.94-1.16],0.4275148037408008
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",15226,1292,1.04 [0.94-1.15],0.458198410702341
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,19248,309,1.11 [0.90-1.36],0.3210744649709233
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,17622,106,1.05 [0.73-1.52],0.7856709105990215
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,18997,58,0.94 [0.55-1.58],0.8059938757306898
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,18893,2836,1.02 [0.95-1.10],0.509115126172694
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,18123,60,1.10 [0.69-1.76],0.6898119994344805
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,19126,54,0.80 [0.44-1.44],0.4587825898765896
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,19102,1586,1.02 [0.93-1.12],0.6679425818578812
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,19100,1584,1.02 [0.93-1.12],0.6656661890670605
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,17612,96,0.90 [0.59-1.37],0.6134837673859094
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,19206,1143,1.02 [0.91-1.14],0.7037020427113669
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,19173,101,1.16 [0.82-1.64],0.395796699657433
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,18996,57,1.14 [0.72-1.82],0.5731601533367174
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,19010,71,0.48 [0.27-0.85],0.0123368136513536
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,19350,278,1.14 [0.92-1.41],0.2174318926342603
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,19400,31,0.72 [0.32-1.60],0.4172936575733275
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",19301,229,1.25 [1.00-1.55],0.0478569139939611
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,18170,107,1.12 [0.79-1.58],0.516499593494488
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,13190,328,1.00 [0.81-1.24],0.992496373327318
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,18256,89,0.86 [0.54-1.37],0.5198052617966469
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,18257,90,0.60 [0.37-0.97],0.0390705084886618
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,12923,61,0.96 [0.57-1.61],0.8740737739134821
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,18148,43,0.76 [0.39-1.50],0.4343055009273687
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,17545,259,1.04 [0.82-1.31],0.7749799753449788
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",18871,752,1.03 [0.89-1.18],0.7054849257668488
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,18526,407,0.98 [0.81-1.18],0.8047139284607718
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,18264,145,1.09 [0.80-1.47],0.5951315454361583
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,19281,1176,0.85 [0.75-0.96],0.0097487435566033
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,16505,1146,0.85 [0.75-0.96],0.0085304926479526
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",12931,69,1.39 [0.96-2.00],0.0789679471416226
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",17626,86,1.00 [0.66-1.51],0.9983251196399452
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,13153,291,1.06 [0.85-1.32],0.6088407971061331
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,12910,48,0.93 [0.52-1.67],0.8187634463415916
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,16673,3811,1.03 [0.97-1.10],0.3530755850280448
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,13088,226,1.04 [0.81-1.34],0.7630491746593443
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,13443,581,1.08 [0.93-1.26],0.2998494035814646
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,19458,299,1.17 [0.96-1.43],0.1298872908112937
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,19276,117,1.35 [1.01-1.80],0.0400569413419389
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,12987,125,1.17 [0.86-1.59],0.3184388646249532
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",12928,66,1.47 [1.06-2.03],0.0215599160997495
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,18970,1430,0.98 [0.88-1.08],0.6406707948933095
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,13161,299,1.04 [0.84-1.29],0.7224288271350034
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,13178,316,1.12 [0.91-1.36],0.2859220802368261
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",13572,710,1.11 [0.97-1.27],0.146361171510264
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,12986,124,1.06 [0.76-1.47],0.7435689865384016
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,19270,111,1.33 [0.99-1.79],0.0618758178657432
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,13595,733,0.97 [0.84-1.13],0.7274372237761815
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,13399,537,1.14 [0.98-1.33],0.0806196497681238
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,17343,57,1.33 [0.88-2.02],0.1727060192235657
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,18203,5341,1.02 [0.97-1.08],0.3599365273012984
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,17589,49,0.56 [0.28-1.11],0.0977435755473338
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,17584,44,0.91 [0.49-1.68],0.7579778445504265
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,19360,1547,1.01 [0.92-1.12],0.7863681778049698
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",19359,1546,1.02 [0.92-1.12],0.757866526578204
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,17593,53,0.91 [0.52-1.60],0.7457330328447644
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,19208,956,0.93 [0.82-1.06],0.294065817297665
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",14670,1808,1.03 [0.95-1.13],0.4576890080645249
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,19494,244,1.08 [0.86-1.37],0.4966261138341062
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,18213,94,1.06 [0.72-1.56],0.7815266122881608
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,18352,100,0.91 [0.61-1.37],0.6618614266594575
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,18394,142,1.08 [0.79-1.46],0.6445475988680054
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",13024,162,1.21 [0.93-1.58],0.1493341098132313
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,17187,155,0.99 [0.73-1.34],0.9453642761821246
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2071,82,1.68 [1.19-2.38],0.003457426356615
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2206,248,0.82 [0.62-1.08],0.1618241880533343
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,17100,68,0.76 [0.46-1.28],0.3041162592954288
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2037,49,1.72 [1.09-2.71],0.0195577644231913
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,18824,1792,0.88 [0.80-0.97],0.0094756891123375
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,18621,502,1.03 [0.87-1.22],0.7337808648936971
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,17653,367,1.05 [0.85-1.28],0.6654024083316181
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,13740,878,1.02 [0.90-1.16],0.7296772591098666
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",19396,263,1.09 [0.87-1.36],0.4428925841915724
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),18274,223,1.10 [0.86-1.40],0.4554697745941428
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Angina pectoris,16912,1275,1.08 [0.97-1.20],0.1423374362839946
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Aortic aneurysm,18359,308,1.12 [0.91-1.37],0.2776849710481532
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,18117,66,1.01 [0.62-1.64],0.9697433309282226
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",18283,232,1.16 [0.92-1.46],0.200462744156595
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,9970,2338,1.02 [0.95-1.11],0.5494215774145131
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,AV-block,14957,543,1.02 [0.86-1.19],0.8440110795451401
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",19435,457,1.12 [0.95-1.32],0.1832499552422124
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Cardiac arrest,7853,221,1.18 [0.93-1.50],0.1795934466526044
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Cardiomyopathy,14590,176,0.84 [0.61-1.16],0.2864989731778358
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",14503,89,0.68 [0.42-1.11],0.1199717108618301
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,19501,62,1.13 [0.72-1.77],0.6047135312764199
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Conduction disorders,15663,1249,0.99 [0.89-1.10],0.8727635856582949
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,17908,2293,1.11 [1.03-1.20],0.0070806364532047
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,15799,7491,1.03 [0.99-1.08],0.1895338122547912
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,DVT of lower extremities,18208,287,1.12 [0.90-1.38],0.3079538956420444
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Endocarditis,14491,77,1.13 [0.75-1.70],0.5610882734316115
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Heart failure, strict",19260,1347,1.05 [0.95-1.17],0.3059916527075212
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Hypertension,16820,6634,1.02 [0.97-1.07],0.4228456939422815
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Hypertension, essential",16825,6639,1.02 [0.97-1.07],0.4271191472051988
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Hypertension, portal",19363,81,1.26 [0.88-1.79],0.2035308995104892
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",10420,234,0.95 [0.74-1.22],0.6979531868331503
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,10308,122,1.13 [0.82-1.54],0.4632163988975167
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Hypotension,19358,1293,1.02 [0.92-1.13],0.7401077783891934
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,18450,123,0.99 [0.70-1.40],0.950178509425596
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",18048,2411,1.09 [1.02-1.18],0.0178662125097867
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",19095,661,0.95 [0.81-1.11],0.5177491770957008
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Left bundle-branch block,14826,412,0.96 [0.79-1.17],0.695643823267404
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,18951,875,1.12 [0.99-1.26],0.0764247722125975
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",16388,751,1.15 [1.01-1.31],0.0376291309025226
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",19393,162,1.17 [0.89-1.54],0.2653509754039861
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",19467,333,1.18 [0.97-1.42],0.0909122088351421
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Oesophageal varices,17979,58,1.34 [0.91-1.98],0.1393524962350062
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other aneurysm,18136,85,1.17 [0.80-1.71],0.4171532183663821
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other arrhythmias,14901,487,0.94 [0.78-1.12],0.476996427641192
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,18158,107,1.00 [0.68-1.47],0.9980075305622574
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,18319,268,1.04 [0.83-1.32],0.7168328369476986
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,14602,188,0.91 [0.67-1.22],0.5193620023429641
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other disorders of veins,18005,84,0.94 [0.61-1.46],0.7938316246653914
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,17958,37,1.56 [0.99-2.47],0.055620258481468
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,17818,72,1.04 [0.67-1.61],0.8728339201509594
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,18060,139,0.97 [0.70-1.36],0.8740259317113299
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,15588,1174,1.03 [0.93-1.15],0.5580916186419216
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,18116,51,1.43 [0.95-2.14],0.0832338435484233
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,18647,596,1.12 [0.97-1.30],0.1212710631855873
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,18865,451,1.00 [0.84-1.20],0.9900369552857632
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",18543,797,1.06 [0.93-1.21],0.3498091235048643
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,7979,347,1.14 [0.94-1.39],0.1875823495831996
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Peripheral artery disease,18503,482,1.11 [0.94-1.31],0.2153254353144379
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),18276,355,1.07 [0.88-1.31],0.4772774191891729
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Pulmonary embolism,18905,491,1.11 [0.95-1.31],0.1995473028918174
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,19420,787,0.98 [0.85-1.13],0.7857830009719147
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Right bundle-branch block,14832,418,0.98 [0.81-1.19],0.8553707007610127
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Secondary right heart disease,18861,447,1.00 [0.83-1.20],0.985530402682574
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,17961,215,1.14 [0.89-1.45],0.2992968164650195
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",19079,752,0.96 [0.83-1.11],0.5557414102085388
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",19068,783,0.96 [0.83-1.11],0.5721121736025848
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,18425,49,0.69 [0.36-1.34],0.2735394950880227
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,18132,81,1.22 [0.83-1.77],0.3115578785902388
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Transient ischemic attack,18687,253,0.96 [0.75-1.23],0.7552279491719652
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,18349,273,1.07 [0.85-1.34],0.5831842838454109
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Varicose veins,18344,423,1.03 [0.86-1.24],0.7185558697971159
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,18066,97,0.56 [0.35-0.91],0.0199338243252455
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Venous thromboembolism,19272,779,1.08 [0.95-1.23],0.2483340087055271
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",19437,279,0.81 [0.62-1.05],0.1067005762084988
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",16751,1163,0.94 [0.84-1.06],0.3361470870802615
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Any mental disorder,19070,3482,0.94 [0.88-1.00],0.0664147893818207
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",19412,330,0.82 [0.64-1.04],0.0948426994941223
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",16784,1196,0.85 [0.76-0.96],0.0088153347397982
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",15649,61,1.20 [0.78-1.86],0.4086451124612779
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Smoking dependency,19083,972,0.92 [0.80-1.07],0.3033942794540817
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",16791,1203,0.90 [0.81-1.01],0.077398502938951
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Vascular dementia,18799,196,0.99 [0.75-1.30],0.94036892101
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Alzheimer disease,19502,498,0.93 [0.78-1.11],0.4200345173445268
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",12164,96,1.27 [0.93-1.75],0.1334233436353217
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Bell's palsy,17985,71,1.23 [0.82-1.84],0.3242500278692651
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,18332,418,0.88 [0.72-1.08],0.2208849388801287
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Cerebral cysts,19143,205,1.07 [0.82-1.38],0.6300823506870232
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,19441,323,1.03 [0.83-1.27],0.8119494417055668
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,18818,71,0.98 [0.62-1.56],0.9265692875208492
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,19487,59,1.43 [0.98-2.08],0.0609397827629189
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",19008,70,0.99 [0.63-1.57],0.9753342517236449
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Epilepsy,18279,240,0.81 [0.62-1.07],0.1376918894916443
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,19121,1082,0.90 [0.79-1.01],0.0805019111680568
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,19453,528,0.98 [0.83-1.16],0.8336745105323103
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Falls/tendency to fall,18949,2805,0.97 [0.90-1.05],0.4742527093517933
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Generalized epilepsy,19202,44,0.61 [0.30-1.24],0.1742833669866984
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Hemiplegia,19382,264,1.11 [0.88-1.38],0.3772112241455007
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Hydrocephalus,18996,58,0.67 [0.37-1.22],0.1881936102250141
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,19490,57,1.26 [0.83-1.92],0.2725837149438205
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,17974,60,1.21 [0.78-1.89],0.3958147310935631
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,17976,62,1.22 [0.79-1.90],0.3675040651686977
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Memory loss,18585,128,0.80 [0.55-1.17],0.2530112593573089
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Migraine,18271,232,0.88 [0.68-1.16],0.3711296093384379
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",19460,214,0.86 [0.65-1.14],0.2918994644470888
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Motor neuron disease,12250,161,1.02 [0.76-1.38],0.8950063933312815
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,19395,47,1.02 [0.57-1.82],0.9458018241035356
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",18925,1011,1.04 [0.92-1.17],0.5358439379648052
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Neurological diseases,18276,3453,1.00 [0.93-1.07],0.953119815328305
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,18983,236,1.04 [0.82-1.33],0.7269582818749267
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",18244,330,1.08 [0.88-1.33],0.4380514467583385
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",19439,282,0.97 [0.77-1.23],0.8190720662196623
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,14798,791,0.99 [0.86-1.14],0.8676862246309747
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,19004,66,0.59 [0.33-1.05],0.0707574544375402
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other disorders of nervous system,19070,132,0.84 [0.58-1.21],0.3506453437994024
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,19103,178,1.12 [0.85-1.46],0.4237231572490425
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other facial nerve disorders,17992,78,1.22 [0.82-1.80],0.3270081779945749
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other headache syndromes,18083,44,0.74 [0.38-1.44],0.3816817787692982
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other neurological diseases,19410,472,0.91 [0.76-1.10],0.3322986975096837
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other sleep disorders,18449,410,0.90 [0.73-1.10],0.2912721945748915
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Parkinson's disease,19471,333,0.92 [0.74-1.15],0.4766648197403521
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,18975,37,0.77 [0.38-1.57],0.4693751736588005
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Restless leg syndrome,19501,78,1.02 [0.66-1.57],0.92654984376732
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Sleep apnoea,19317,352,0.90 [0.72-1.12],0.3435547902944049
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Small fibre neuropathy,19207,50,0.88 [0.49-1.57],0.6630403579474644
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,19490,181,1.07 [0.81-1.40],0.6431839965182626
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,17975,61,1.36 [0.91-2.01],0.130481744167221
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,19502,503,0.95 [0.80-1.14],0.5979671911817029
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),18744,190,0.97 [0.73-1.29],0.850674590287263
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,18973,127,0.96 [0.68-1.36],0.8183775969316275
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,19138,477,0.92 [0.77-1.11],0.3925509355430321
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,19301,219,0.79 [0.59-1.06],0.1121601573696365
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,18477,59,1.03 [0.63-1.67],0.9116139255265784
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,18451,33,1.20 [0.67-2.14],0.5364936028246678
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",19399,63,1.15 [0.74-1.77],0.5366278421973177
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,19243,192,1.06 [0.81-1.39],0.678666794630121
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2041,52,1.71 [1.10-2.66],0.016723882275027
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2512,93,1.57 [1.12-2.19],0.0084988242258851
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,18935,89,0.79 [0.50-1.24],0.3031781150235437
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,19270,1190,1.01 [0.90-1.13],0.9142155848005584
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",19146,728,1.10 [0.96-1.26],0.1624018875505879
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,18671,253,1.05 [0.83-1.33],0.6613294331981256
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",19450,789,0.93 [0.81-1.07],0.3184139742176398
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,19496,69,1.03 [0.65-1.63],0.9056570181141856
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,19398,737,0.93 [0.81-1.08],0.3677465469083516
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",19467,416,1.13 [0.95-1.34],0.1801357439312396
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,19401,186,1.09 [0.83-1.42],0.5486083808869362
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,18501,83,1.35 [0.97-1.87],0.0732536967025285
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,18504,86,0.92 [0.60-1.43],0.7187841235344973
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,18484,66,0.89 [0.54-1.47],0.6462240791211625
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,19392,845,0.94 [0.82-1.08],0.405622203265528
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,18771,224,0.91 [0.70-1.20],0.509668855725172
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,18717,56,0.75 [0.41-1.35],0.3325342743275598
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,19155,104,1.04 [0.72-1.50],0.8199429827949787
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,19374,323,1.17 [0.96-1.42],0.1197905428561194
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,18844,183,1.10 [0.84-1.44],0.4735535440698512
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,19330,115,1.19 [0.87-1.64],0.2789098637321087
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,19101,554,0.91 [0.77-1.08],0.2894131537989821
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,18982,136,0.90 [0.63-1.27],0.5438755341578985
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,17468,2709,1.04 [0.97-1.12],0.2420704818036171
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,19340,289,1.19 [0.97-1.46],0.0885003305135569
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,19487,158,1.06 [0.79-1.42],0.7010026745475477
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,18865,447,1.17 [1.00-1.38],0.0552810427652578
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,19127,76,1.32 [0.93-1.87],0.1222521653547631
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,19489,62,1.05 [0.65-1.69],0.8506257439124632
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,18526,108,1.22 [0.88-1.67],0.2280564756802253
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,18567,149,1.20 [0.91-1.58],0.1986259471235886
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,18215,135,0.93 [0.66-1.32],0.6816212340993855
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,18707,46,0.79 [0.42-1.49],0.4620502110213296
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",18144,64,1.20 [0.77-1.87],0.4155822281444432
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,18645,98,0.81 [0.53-1.26],0.3505959401197712
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",18788,241,0.91 [0.70-1.19],0.4959149428594382
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,18544,126,1.07 [0.77-1.48],0.707191586305725
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,18158,78,0.74 [0.45-1.22],0.2349479079500053
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,18184,104,1.11 [0.77-1.59],0.5773434050723016
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,17013,2254,0.93 [0.85-1.01],0.0842644569811498
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,18499,81,1.27 [0.90-1.81],0.1760430427552818
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,19265,419,0.98 [0.81-1.19],0.871253317377436
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,18910,64,1.14 [0.73-1.78],0.5623697244059941
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),19004,158,0.96 [0.70-1.31],0.8034131352761997
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,19308,91,0.89 [0.58-1.37],0.6011605913126903
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,19467,116,1.29 [0.96-1.74],0.0895533756085231
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,19393,94,1.13 [0.78-1.63],0.5228658126142427
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,19273,56,0.94 [0.55-1.60],0.8153838493921849
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,19274,57,1.25 [0.81-1.92],0.3121428452777086
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,19410,1002,1.07 [0.95-1.20],0.2787930728550177
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,19167,759,1.14 [1.00-1.29],0.0513304000709004
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,18531,123,0.85 [0.58-1.24],0.4029704320645678
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,18484,76,1.01 [0.65-1.57],0.9495222093402454
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Acute pharyngitis,19336,51,0.87 [0.49-1.55],0.6306177690156878
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,19436,151,0.72 [0.50-1.03],0.0727132748177386
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,19335,50,0.60 [0.31-1.16],0.126658618427741
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,All influenza,17336,120,0.86 [0.59-1.26],0.4403107036008078
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),17334,118,0.84 [0.57-1.24],0.3885179007978051
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Allergic asthma (mode),12112,83,1.19 [0.82-1.72],0.3674478093027914
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Allergic rhinitis,19422,203,1.14 [0.89-1.47],0.2916015628786804
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",13182,1468,1.03 [0.93-1.14],0.5543129330241157
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",13481,1452,1.02 [0.93-1.13],0.6347023432325951
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),19073,146,0.81 [0.56-1.15],0.2361221472237202
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",17301,85,0.75 [0.46-1.21],0.2378647671254802
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Bronchiectasis,16329,424,0.97 [0.80-1.17],0.7684637409978541
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",15964,59,1.16 [0.73-1.84],0.5309140348102921
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,18560,2655,1.02 [0.94-1.09],0.6751213403811
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",18466,67,0.84 [0.50-1.41],0.5210832150072928
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Chronic sinusitis,18510,111,1.02 [0.71-1.46],0.9061517758918252
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",19257,1343,0.98 [0.88-1.09],0.7136161091711917
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Deviated nasal septum,18467,68,0.99 [0.62-1.58],0.9613764241214732
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,17696,5071,1.03 [0.97-1.08],0.3434631607397217
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",18690,291,0.84 [0.65-1.07],0.1632494878282339
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Early onset COPD,18014,100,1.15 [0.80-1.65],0.4607190016325194
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Emphysema,16269,364,1.01 [0.83-1.24],0.9143425377306088
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,18391,391,0.92 [0.75-1.12],0.398134662517916
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Influenza and pneumonia,19282,2066,0.95 [0.87-1.03],0.2245928543485087
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Interstitial lung disease,18426,426,0.93 [0.77-1.13],0.4612417377250665
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Later onset COPD,19050,1243,0.97 [0.86-1.08],0.5442630557022907
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,19488,380,0.95 [0.78-1.17],0.6327782013494894
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Nasal polyp,18479,80,1.14 [0.77-1.69],0.5005127346636544
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,19262,1040,1.00 [0.89-1.13],0.9952961090334624
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other diseases of pleura,19261,2221,0.99 [0.91-1.07],0.7543936127907171
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,19039,640,0.96 [0.82-1.13],0.6392152306016502
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other pleural conditions,17091,51,0.96 [0.55-1.67],0.8800027811017079
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,19392,499,0.91 [0.76-1.09],0.2819894367445982
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,19392,1433,0.96 [0.87-1.07],0.4778457823935581
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Pleural effusion,18139,1099,0.97 [0.86-1.09],0.5686122029962519
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Pleural plaque,17254,214,1.05 [0.82-1.36],0.6906583292547768
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",19049,1833,0.98 [0.89-1.07],0.5969461850089648
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,19393,285,1.05 [0.84-1.32],0.643067428732176
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Pneumothorax,17187,147,0.90 [0.64-1.27],0.5476486592806038
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Pollen allergy,19493,171,1.03 [0.77-1.38],0.8224558727072337
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Pulmonary oedema,18966,73,0.83 [0.51-1.36],0.4671759463782079
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Respiratory insufficiency,12089,60,0.86 [0.52-1.44],0.5702652908721024
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,19248,1026,1.01 [0.89-1.14],0.9027032355759672
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,18603,204,1.14 [0.88-1.46],0.3195200974584125
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Viral pneumonia,17456,240,0.81 [0.61-1.06],0.1286268698479592
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",19087,192,0.81 [0.59-1.10],0.1755818718647678
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,6300,103,0.68 [0.43-1.08],0.1041545974805545
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,12476,49,0.89 [0.49-1.63],0.7103878101619698
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Acute appendicitis,19401,109,1.12 [0.79-1.58],0.5222955856994871
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Acute gastritis,13632,81,1.20 [0.83-1.74],0.3380986031960926
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Acute pancreatitis,17824,161,1.09 [0.82-1.45],0.5529909359839293
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Acute peritonitis,19097,89,1.11 [0.75-1.63],0.6097073178774428
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Alcoholic liver disease,18685,49,1.23 [0.76-2.00],0.4058486860201405
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Barrett oesophagus,13967,416,1.11 [0.94-1.33],0.2210981998304242
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",17783,120,1.20 [0.88-1.63],0.2491639282518386
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",19162,120,1.20 [0.88-1.64],0.24345775634765
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Cholecystitis,17842,179,0.90 [0.66-1.22],0.5056456239078357
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Cholelithiasis,18535,872,0.95 [0.84-1.09],0.4934299148602489
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Chronic gastritis,13836,285,1.06 [0.85-1.32],0.5900146834593722
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Chronic pancreatitis,17707,44,1.01 [0.57-1.80],0.9778241232711476
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",19390,108,1.07 [0.75-1.53],0.6986820991824279
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Coeliac disease,18062,103,1.36 [1.01-1.83],0.0445377894826681
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Collagenous colitis,18038,88,1.30 [0.92-1.84],0.1332241293470153
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,19405,143,1.07 [0.78-1.46],0.6698626997320603
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Constipation,19260,1732,1.01 [0.92-1.10],0.8973996101376828
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Crohn disease,18015,65,0.73 [0.42-1.27],0.2654812139140688
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",19212,49,0.82 [0.45-1.50],0.522584351587005
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Crohn's disease NAS,18009,59,0.64 [0.35-1.16],0.1394788667056256
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Dental caries,18983,159,1.29 [0.99-1.68],0.0557099275334294
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,16907,2142,1.00 [0.93-1.09],0.922392783752745
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of appendix,19427,135,1.19 [0.88-1.60],0.2581760920264687
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of liver,19408,772,1.01 [0.88-1.17],0.8330998616853238
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",17383,3832,1.04 [0.98-1.11],0.1653151009764323
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",19217,393,1.13 [0.94-1.35],0.2013340788207901
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of peritoneum,19430,422,1.06 [0.88-1.27],0.5347134306802235
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,18900,76,0.90 [0.56-1.44],0.6601987775771953
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of salivary glands,18797,43,1.19 [0.69-2.03],0.5306674823338084
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of the digestive system,19230,1271,0.99 [0.89-1.10],0.8533252299000036
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of tongue,18810,80,0.94 [0.60-1.48],0.7905041351135913
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",18926,1263,0.99 [0.89-1.11],0.8791024997377423
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,15608,3181,1.12 [1.05-1.19],0.0005774689848124
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Duodenal ulcer,13749,198,1.14 [0.89-1.47],0.3044946278929542
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",19415,160,1.19 [0.91-1.56],0.2045626908735794
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,19474,17,1.27 [0.56-2.87],0.569480786688297
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,18763,127,1.09 [0.79-1.51],0.5943498954644
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,12522,95,1.29 [0.91-1.82],0.1467757962820585
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Functional dyspepsia,14029,478,0.82 [0.67-1.00],0.0454112969864378
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Gastric ulcer,13912,361,1.09 [0.90-1.33],0.3662157861964301
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,15767,2216,1.02 [0.94-1.10],0.6370464235579861
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,14091,540,1.11 [0.95-1.30],0.1953995715468845
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,14172,6913,1.03 [0.98-1.08],0.240553149212191
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,GI-bleeding,19003,1044,0.98 [0.87-1.11],0.7927340096792448
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,18868,44,0.64 [0.32-1.28],0.2068514730873939
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,13264,998,0.95 [0.84-1.09],0.4815435918833703
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",18695,59,1.36 [0.91-2.03],0.1371158574051755
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Hernia,17787,3022,0.96 [0.90-1.04],0.3191513690922308
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Impacted teeth,19476,16,1.39 [0.63-3.06],0.4206365714551634
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Impaction of intestines,12490,63,0.92 [0.54-1.56],0.7436462376823378
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Inguinal hernia,15669,904,0.88 [0.77-1.01],0.0645988593110041
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",14864,99,0.88 [0.58-1.32],0.5312265293218843
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,12523,96,1.03 [0.69-1.54],0.8935754975876551
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Intestinal malabsorption,18081,122,1.25 [0.93-1.68],0.1477340699063624
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,12856,429,1.15 [0.97-1.38],0.1144882901991172
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,19483,275,0.88 [0.69-1.13],0.3115624978735724
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,18606,656,1.06 [0.92-1.23],0.4145212495986843
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,18863,913,1.08 [0.96-1.22],0.1982016354377327
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Oesophageal obstruction,13733,182,1.12 [0.86-1.46],0.3836326574777224
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Oesophagitis,14138,587,1.00 [0.86-1.18],0.953959282272936
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,19452,113,1.32 [0.98-1.78],0.0681224750932421
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,14835,70,0.52 [0.29-0.92],0.0245397107772655
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,13573,1146,1.08 [0.97-1.21],0.1610685974088299
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,17956,293,1.13 [0.92-1.39],0.2591245111554716
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,17787,124,1.16 [0.85-1.58],0.3467989796344576
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of intestine,14056,1629,1.10 [1.00-1.21],0.0483535884062959
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of intestines,17581,5154,1.06 [1.01-1.12],0.0274838798087524
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,18778,181,1.03 [0.78-1.37],0.8333168834638973
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of liver,19269,633,1.03 [0.89-1.20],0.6904990121831021
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,14187,636,1.13 [0.98-1.30],0.089196810281549
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of pancreas,17834,171,1.20 [0.93-1.55],0.1673164819315633
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,19369,361,1.01 [0.83-1.24],0.9013714196766222
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,14468,917,1.16 [1.03-1.30],0.0107259500880849
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,19015,1056,0.99 [0.88-1.11],0.8669849583031057
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,18967,143,1.53 [1.22-1.92],0.0002661709277384
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,14196,1769,1.03 [0.94-1.13],0.5170831503638291
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),15369,1818,1.04 [0.95-1.14],0.3608777102270543
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,18731,95,1.14 [0.79-1.63],0.4889626092305018
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,18763,813,1.08 [0.95-1.23],0.2362818314624984
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",12786,359,0.98 [0.79-1.21],0.8321125675211213
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,19471,20,1.22 [0.56-2.65],0.6163393868677364
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,12930,503,1.00 [0.83-1.19],0.964347573690542
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",18095,136,0.83 [0.58-1.18],0.2987721027404755
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Recurring oral aphthae,19490,44,0.59 [0.29-1.21],0.1493005500675788
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,18816,83,0.62 [0.37-1.03],0.0672428560138295
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Toxic colitis,18019,69,0.88 [0.54-1.44],0.6045101752519164
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,13840,289,1.13 [0.91-1.39],0.2616064868187343
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Ulcerative colitis,18085,135,1.12 [0.82-1.52],0.474096134395075
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",18059,109,1.17 [0.84-1.62],0.3632335763223642
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Umbilical hernia,14980,215,0.86 [0.65-1.13],0.2779355576415493
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,12628,201,1.03 [0.78-1.36],0.8099788336810556
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Ventral hernia,14988,223,0.97 [0.75-1.26],0.8080705934128674
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Volvulus,12502,75,0.80 [0.48-1.33],0.3861122463264771
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,19417,342,1.10 [0.91-1.34],0.3232486004862621
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,19202,61,1.10 [0.69-1.74],0.6890681777381715
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,17399,141,1.17 [0.87-1.56],0.2912894021204695
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,18977,687,0.89 [0.76-1.03],0.1252446489878982
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",18410,120,0.90 [0.62-1.31],0.584019909011318
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,17749,491,0.99 [0.83-1.18],0.9134323758549018
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,19211,256,0.87 [0.67-1.13],0.285195097664132
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,19410,455,0.99 [0.83-1.19],0.9209045183033564
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,18998,43,0.90 [0.49-1.66],0.7383532833792491
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,18149,3084,1.00 [0.93-1.07],0.9856606754764946
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,19132,365,1.14 [0.94-1.37],0.1798895047700149
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,19019,252,1.14 [0.91-1.43],0.2476012018694055
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,19183,893,0.91 [0.79-1.04],0.1714609292400484
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",19486,49,1.23 [0.77-1.96],0.3909593985193167
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,17312,54,1.17 [0.72-1.91],0.5138695506928054
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,18819,52,0.93 [0.54-1.61],0.7902931585739446
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,19199,244,0.86 [0.66-1.12],0.2650377212348309
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,17759,501,1.00 [0.84-1.18],0.9784856678974864
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,17333,75,1.24 [0.84-1.81],0.2759526960342765
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,19429,69,0.92 [0.57-1.51],0.7520374997611387
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,18471,181,1.14 [0.88-1.48],0.312718349695894
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,19332,191,0.94 [0.70-1.25],0.65577738938897
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,19027,72,0.99 [0.63-1.56],0.96527346949037
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,17317,59,0.73 [0.41-1.30],0.2817333256490706
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,18976,1718,0.99 [0.91-1.09],0.9157553711262548
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",17797,539,0.98 [0.83-1.16],0.7878762163599549
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,17336,78,1.23 [0.84-1.79],0.2857544769279881
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,19428,287,0.99 [0.79-1.24],0.9444908905414936
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,19020,65,1.24 [0.82-1.87],0.3022187083188543
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,19378,237,0.94 [0.72-1.21],0.6166497497059977
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,19444,369,1.12 [0.93-1.34],0.2348328164224002
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,17366,108,0.84 [0.56-1.25],0.3842318377202713
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,17538,280,0.90 [0.71-1.15],0.4167143655024899
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,19433,358,1.12 [0.93-1.35],0.2156343116679425
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",17521,263,0.92 [0.72-1.18],0.5305643011137158
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,19478,118,1.04 [0.74-1.48],0.8065615634782444
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,16291,65,0.99 [0.61-1.62],0.983232307650502
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,17215,5388,0.98 [0.93-1.03],0.4757386809564663
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,16021,4194,0.98 [0.92-1.04],0.4393567890086086
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,16271,45,1.26 [0.76-2.10],0.3722472417032396
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,16270,116,0.86 [0.58-1.27],0.4408872241613979
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,16304,150,0.88 [0.63-1.24],0.4733144197915789
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,19288,49,0.79 [0.42-1.47],0.4534079417501873
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",16275,121,1.04 [0.73-1.46],0.840510462652113
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,13070,1243,0.93 [0.83-1.04],0.1898155874569132
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",19322,207,0.90 [0.68-1.20],0.4723887366317862
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,16620,466,0.99 [0.82-1.18],0.8735023548324139
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,15824,6744,1.02 [0.98-1.07],0.3577154853208028
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,17413,103,0.90 [0.60-1.34],0.5973103082604861
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,16374,148,0.97 [0.70-1.35],0.8520121245837422
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,16654,428,0.98 [0.81-1.18],0.815347226638021
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,18724,2570,1.01 [0.94-1.09],0.7676420335864806
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,16492,266,1.15 [0.93-1.43],0.2006947292160806
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,16350,124,0.97 [0.68-1.39],0.8874748902629593
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,16327,101,0.84 [0.55-1.29],0.4308905559884713
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,18856,86,0.95 [0.62-1.46],0.8055366392840451
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,13499,1672,0.98 [0.89-1.08],0.6429081619463339
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,12463,636,1.02 [0.88-1.18],0.7776275947803147
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",19420,630,1.06 [0.91-1.22],0.4510442299602404
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,11890,63,0.79 [0.46-1.35],0.3832428683426689
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),12088,261,0.79 [0.61-1.03],0.0841022365981933
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,16443,217,1.14 [0.89-1.45],0.2887647944354296
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,12233,406,1.06 [0.89-1.28],0.5142628838231107
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,16219,65,0.75 [0.44-1.30],0.3104397528458076
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,16705,551,0.96 [0.81-1.14],0.6455478075350778
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,16405,251,0.96 [0.75-1.23],0.7207198111012105
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,12206,379,1.07 [0.89-1.29],0.4754171260166057
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,16285,59,0.86 [0.50-1.48],0.5902874352673331
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",16273,47,1.26 [0.78-2.04],0.3505488710898488
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,17375,65,1.12 [0.73-1.73],0.5912033906556751
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,19148,1838,1.02 [0.93-1.12],0.6419123341599939
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,18609,1299,1.03 [0.92-1.14],0.6220673208222893
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",19362,456,1.14 [0.97-1.35],0.1219526687458445
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,14436,2609,0.98 [0.91-1.06],0.6708385139149846
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,11867,40,0.80 [0.41-1.57],0.5154161589480903
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,16310,84,1.42 [1.03-1.96],0.0309255701558216
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,11892,65,0.63 [0.35-1.12],0.113307994495877
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),11941,114,1.20 [0.88-1.65],0.2475610970253099
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,17512,202,0.85 [0.63-1.14],0.2765362374968997
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,17714,404,1.04 [0.86-1.25],0.6977535688092767
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,19485,88,0.81 [0.51-1.28],0.3635541882574487
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",17771,1617,1.00 [0.91-1.10],0.963895291574798
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,16285,59,1.25 [0.81-1.91],0.3114972732440833
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),11954,127,1.19 [0.88-1.59],0.2531063235565852
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,16803,649,0.99 [0.85-1.15],0.8559444076278113
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,13659,1832,0.97 [0.89-1.06],0.5174599033752513
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,18876,106,1.01 [0.69-1.46],0.9690578677641996
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,19495,58,1.11 [0.70-1.78],0.6542461151532434
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,16293,67,0.84 [0.50-1.41],0.5068881875823283
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",17327,1101,1.02 [0.91-1.15],0.7033909599407697
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,16315,89,0.94 [0.61-1.44],0.7724404858211011
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,13563,1736,1.00 [0.91-1.10],0.9869576687722188
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,17413,103,0.86 [0.57-1.30],0.4672023049044914
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,16252,26,1.21 [0.62-2.37],0.5703894126141971
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,16316,162,0.90 [0.66-1.24],0.5235602764762488
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,16777,551,1.09 [0.93-1.27],0.2833444372448592
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,19183,413,1.05 [0.87-1.26],0.6189633086365047
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,16684,530,1.02 [0.87-1.21],0.7898669228258929
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,19374,452,1.13 [0.96-1.34],0.1457028873240312
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,19481,58,0.89 [0.52-1.52],0.6592514752157732
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,16365,139,0.71 [0.48-1.04],0.0807615015147262
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,15214,718,0.98 [0.84-1.13],0.7421574729389209
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,16747,521,1.02 [0.86-1.20],0.8434068728439867
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],16466,240,1.15 [0.92-1.45],0.215509157146075
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",11887,60,1.15 [0.74-1.79],0.5450133807685102
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,14429,2602,1.00 [0.93-1.08],0.9347488380437972
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,12520,693,1.06 [0.92-1.22],0.4356348718583404
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,19077,307,1.08 [0.88-1.33],0.4365904634176617
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",19457,60,1.05 [0.65-1.70],0.8330332998539437
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",17296,58,0.88 [0.51-1.52],0.6468686630855849
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,11886,59,1.06 [0.66-1.70],0.8062584261794103
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,16243,89,0.88 [0.57-1.36],0.5591109978987854
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,12290,463,1.14 [0.96-1.34],0.1294506792900028
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,16506,280,1.05 [0.84-1.32],0.679088801541355
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,16393,239,0.92 [0.71-1.19],0.5145253853156873
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,16365,211,1.10 [0.86-1.41],0.4565669828656988
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,13766,59,1.03 [0.63-1.68],0.9182936739806667
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",19485,62,0.85 [0.50-1.44],0.5412505020076294
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,16683,457,1.08 [0.91-1.29],0.3722727227804839
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],18855,85,1.09 [0.73-1.62],0.6675365068258006
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,18406,2180,1.06 [0.98-1.15],0.1376566025556244
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",16350,124,0.96 [0.67-1.37],0.8117662605205063
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,16715,561,1.11 [0.95-1.29],0.1919619976716771
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,18346,224,0.83 [0.62-1.10],0.1875130960654202
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,16351,197,0.96 [0.72-1.27],0.7561231702066411
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,17772,1618,1.04 [0.95-1.14],0.3845305669454419
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,17211,1057,1.07 [0.95-1.20],0.2471554564443512
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],16273,47,1.60 [1.10-2.34],0.0149381428486255
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,18875,105,1.22 [0.87-1.70],0.2433197572326715
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,16367,141,1.31 [1.00-1.71],0.0475989374788445
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,16306,80,1.18 [0.79-1.74],0.4221526700683937
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),11888,61,1.08 [0.68-1.73],0.7366118744772057
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Acute renal failure,18392,1769,1.07 [0.98-1.17],0.1338250713701418
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),7849,23,1.76 [1.10-2.83],0.0192594710071546
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,9962,27,0.66 [0.28-1.58],0.3520027028757343
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,19234,259,0.96 [0.75-1.23],0.7581357638139224
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,19062,87,1.15 [0.79-1.67],0.4555153580592435
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,18339,1716,1.12 [1.03-1.22],0.0096492332089057
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,19322,87,1.40 [1.03-1.91],0.0311382748372482
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,19279,332,1.08 [0.88-1.32],0.4421685509319351
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Cystitis,16361,255,0.92 [0.71-1.18],0.4987063653999298
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Dialysis,16690,67,1.59 [1.17-2.16],0.0031325506099088
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,8563,1779,1.01 [0.92-1.10],0.9106650615274416
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Disorders of breast,10038,103,0.94 [0.64-1.39],0.7643375334651619
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Endometriosis,7860,34,1.68 [1.09-2.59],0.0178363845492201
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,8312,486,1.03 [0.87-1.23],0.7194231771354425
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,16125,5165,1.04 [0.98-1.09],0.195396136568362
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,19302,67,1.38 [0.96-2.00],0.085479811796246
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Hydrocele,6884,100,0.92 [0.61-1.40],0.6992319626984118
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,16657,277,0.92 [0.73-1.18],0.5264728204838409
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,8297,1513,0.99 [0.90-1.10],0.8998894838054458
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,10090,139,0.92 [0.66-1.30],0.6442454292973399
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),6888,104,0.77 [0.50-1.19],0.2395047009190262
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,16177,71,1.11 [0.73-1.70],0.6191220119191811
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,8695,869,1.05 [0.92-1.19],0.4762025551447956
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,6835,51,1.01 [0.57-1.76],0.9856408397407592
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,7859,33,1.25 [0.70-2.24],0.4478653852439641
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",19496,74,0.76 [0.46-1.27],0.2906531696510769
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",19490,71,0.95 [0.60-1.53],0.8469938533346636
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,18507,2401,1.00 [0.92-1.08],0.9622440533835344
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,16901,795,1.01 [0.88-1.15],0.9335693456103344
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,9978,43,1.39 [0.88-2.20],0.1540273866942694
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,19440,493,1.08 [0.92-1.28],0.3478279521329042
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,6904,120,1.00 [0.70-1.44],0.9792815616215552
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,6917,133,1.10 [0.80-1.51],0.563729917899785
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,6908,124,0.85 [0.58-1.24],0.4024750240290364
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,19473,69,1.15 [0.76-1.75],0.5120443305121126
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,17976,1870,0.99 [0.91-1.08],0.8388461627817901
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,10023,72,0.71 [0.42-1.20],0.1973513621501066
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,7891,65,1.29 [0.87-1.92],0.2003374665778582
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",7958,132,1.26 [0.94-1.68],0.1253584234732957
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,7874,48,1.06 [0.61-1.81],0.8433417984887824
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,7912,86,0.98 [0.64-1.51],0.9322683358026888
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,16706,326,1.02 [0.83-1.26],0.8636383911485259
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,19106,159,1.06 [0.78-1.42],0.7241492030207047
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,7931,105,1.03 [0.71-1.50],0.8760715100568093
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,7846,20,0.74 [0.27-2.01],0.5536852354851477
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,8007,181,1.46 [1.17-1.82],0.0008110839169609
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,7907,81,0.95 [0.61-1.49],0.8331516752977253
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,8003,177,1.24 [0.96-1.61],0.1034916613288496
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,19280,45,1.02 [0.58-1.78],0.9555436840839988
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",6911,127,0.98 [0.69-1.39],0.9055551287693738
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,19297,2917,1.08 [1.01-1.16],0.0213994016327613
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",16452,72,1.52 [1.11-2.08],0.0087139765352575
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,16761,138,1.19 [0.89-1.58],0.2432480249830487
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,19009,34,0.90 [0.45-1.80],0.757312992012571
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Urethral stricture,16333,227,1.05 [0.82-1.35],0.673853409465595
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Urolithiasis,19309,334,0.98 [0.79-1.22],0.8810122833128073
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Uterine polyps,7858,32,1.79 [1.17-2.73],0.007005751167397
